SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe E. who wrote (3114)12/3/1997 6:23:00 PM
From: Oliver & Co   of 6136
 
<It seems temporarily to have been forgotten that Agouron is the company that took control of a research compound from which a major pharmaceutical company had withdrawn financial support, successfully obtained FDA approval after completing one of the fastest development programs in the history of the US Pharmaceutical industry, and itself launched a drug in the US which after seven months has overtaken its three competitors to become the leader of its class in dollar market share, and appears to be on its way to generating greater first year sales than any other product from the biotech industry>.
======================================================================

Maybe he is telling us that this is just what they wanted. They are the only ones who know what their MMP Inh does. If it works like I was told, then get Roche and any other blood sucker out.

JLL
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News